BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37498119)

  • 21. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
    Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
    Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
    Park JY; Nam JH
    Oncologist; 2015 Mar; 20(3):270-8. PubMed ID: 25673106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.
    Kohn JR; Katebi Kashi P; Acosta-Torres S; Beavis AL; Christianson MS
    J Minim Invasive Gynecol; 2021 Mar; 28(3):392-402. PubMed ID: 33373729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
    Mitsuhashi A; Kawasaki Y; Hori M; Fujiwara T; Hanaoka H; Shozu M
    BMJ Open; 2020 Feb; 10(2):e035416. PubMed ID: 32114477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer.
    Park JY; Seong SJ; Kim TJ; Kim JW; Bae DS; Nam JH
    Gynecol Oncol; 2017 Jul; 146(1):39-43. PubMed ID: 28526167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.
    Contreras NA; Sabadell J; Verdaguer P; Julià C; Fernández-Montolí ME
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Greenwald ZR; Huang LN; Wissing MD; Franco EL; Gotlieb WH
    Cancer; 2017 May; 123(9):1545-1554. PubMed ID: 28026855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
    Yamagami W; Susumu N; Makabe T; Sakai K; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
    J Gynecol Oncol; 2018 Mar; 29(2):e21. PubMed ID: 29400014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
    De Rocco S; Buca D; Oronzii L; Petrillo M; Fanfani F; Nappi L; Liberati M; D'Antonio F; Scambia G; Leombroni M; Dessole M; Lucidi A
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():90-97. PubMed ID: 35526471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of cranial bone metastasis after fertility-sparing approach in endometrial cancer.
    Birge Ö; Bakır MS; Sağnıç S; Dinc C; Tuncer HA; Simsek T
    J Obstet Gynaecol; 2022 Jul; 42(5):1597-1599. PubMed ID: 34996332
    [No Abstract]   [Full Text] [Related]  

  • 31. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
    Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine sparing management in patients with endometrial cancer: a narrative literature review.
    Zisi M; Zygouris D; Tsonis O; Papadimitriou S; George M; Kalantaridou S; Paschopoulos M
    J Obstet Gynaecol; 2022 Jul; 42(5):823-829. PubMed ID: 34989284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of hysteroscopy in fertility preservation in endometrial cancer and atypical endometrial hyperplasia: a semi-systematic literature review.
    Bilir E; Kahramanoğlu İ
    Arch Gynecol Obstet; 2023 Oct; 308(4):1113-1126. PubMed ID: 36807742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
    Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
    Yang HC; Liu JC; Liu FS
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):90-93. PubMed ID: 30638488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
    Shikeli S; Gowri V; Rawahi TA
    JBRA Assist Reprod; 2020 Oct; 24(4):466-469. PubMed ID: 32569453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature.
    Arendas K; Aldossary M; Cipolla A; Leader A; Leyland NA
    J Minim Invasive Gynecol; 2015 Jan; 22(1):34-9. PubMed ID: 25196160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
    Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
    Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility preserving treatment for gynecologic malignancies: a review of recent literature.
    Coakley K; Wolford J; Tewari KS
    Curr Opin Obstet Gynecol; 2020 Feb; 32(1):51-56. PubMed ID: 31851046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.